Publications by authors named "John Fort"

Claim this Profile
E
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial.
Kristin A Shimano, Amanda B Grimes, Shipra Kaicker, Sanjay J Shah, Elizabeth Gunn, John Fort

JAMA· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia.
Reema Kashif, Biljana Horn, Jordan Milner, Michael Joyce, Mansi Dalal, John Fort

Pediatr Transplant· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders.
Ally Fraser, Paul Castillo, Erika Cascio, Giselle Moore-Higgs, Nosha Farhadfar, John Fort

Pediatr Blood Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race as a factor in donor selection and survival of children with hematologic malignancies undergoing hematopoietic stem cell transplant in Florida.
Biljana Horn, Nikhil Lamba, Deepak Chellapandian, Gauri Sunkersett, Jorge Galvez Silva, John Fort

Pediatr Blood Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric HCT in Florida (2014 -2016): A report from the FPBCC.
Deepak Chellapandian, Gauri Sunkersett, Benjamin Oshrine, Jorge Galvez Silva, Edward Ziga, John Fort

Pediatr Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary pulmonary artery sarcoma in the pediatric patient: Review of literature and a case report.
Yong Yean Kim, Tung Thanh Wynn, John David Reith, William B Slayton, Joanne Lagmay, John Fort

Radiol Case Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusion of Hematopoietic Stem Cell Products Using Pump Mechanism: An Approach Worth Consideration?
Trisha Kissoon, Kamar Godder, John Fort

J Pediatr Hematol Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late Effects After Radiotherapy for Childhood Low-grade Glioma.
Noelle L Williams, Ronny L Rotondo, Julie A Bradley, David W Pincus, John A Fort

Am J Clin Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Presentation: Rare Occurrence of an Adolescent Male Presenting With an ATRT and Simultaneous Low-grade Glioneuronal Tumor.
Matthew Cascio, Marie Rivera-Zengotita, John Fort

J Pediatr Hematol Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.
Wenjie Zhang, Yi Han, John G Fort, David Schofield, James P Tursi

J Med Econ· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers.
Kyle Dyson, Marie Rivera-Zengotita, Jesse Kresak, Kristin Weaver, Brian Stover, John Fort

Histopathology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
Jay L Goldstein, James M Scheiman, John G Fort, David J Whellan

J Cardiovasc Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.
Jay L Goldstein, David J Whellan, James M Scheiman, Byron L Cryer, Glenn M Eisen, John G Fort

Cardiovasc Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onset and durability of pain relief in knee osteoarthritis: pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
Robert J Holt, John G Fort, Amy Y Grahn, Jeffrey D Kent, Alfonso E Bello

Phys Sportsmed· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
Robert J Holt, John G Fort, Amy Y Grahn, Jeffrey D Kent, Alfonso E Bello

Phys Sportsmed· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome.
Sushmita Nair, John A Fort, Anthony T Yachnis, Charles A Williams

Pediatr Blood Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.
David J Whellan, Jay L Goldstein, Byron L Cryer, Glenn M Eisen, Angel Lanas, John G Fort

Am Heart J· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local control in non-metastatic medulloblastoma.
Kaitlin M Christopherson, Julie A Bradley, Ronny L Rotondo, David W Pincus, John A Fort

Acta Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Kaitlin M Christopherson, Ronny L Rotondo, Julie A Bradley, David W Pincus, Tung T Wynn, John A Fort

Acta Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Paul A Gurbel, Kevin P Bliden, John G Fort, Young-Hoon Jeong, Alan Shuldiner

Am Heart J· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter by Fort and Plachetka regarding article, "association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from PLATO".
John G Fort, John R Plachetka

Circulation· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
Laurene Wang-Smith, John Fort, Ying Zhang, Mark Sostek

J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
Byron L Cryer, Mark B Sostek, John G Fort, Ola Svensson, Clara Hwang

Ann Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified Severity of Dyspepsia Assessment pain scale: a new tool for measuring upper abdominal pain in osteoarthritis patients taking NSAIDs.
Jennifer Welle, John Fort, Joseph Crawley, Byron Cryer, Rene Dickerhoof

Patient Relat Outcome Meas· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.
Marc C Hochberg, John G Fort, Ola Svensson, Clara Hwang, Mark Sostek

Curr Med Res Opin· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis